These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36455484)

  • 21. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
    Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
    Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
    Han Z; Hao X; Ma B; Zhu C
    Eur J Med Chem; 2016 Oct; 121():308-317. PubMed ID: 27267001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential use of aldose reductase inhibitors to prevent diabetic complications.
    Zenon GJ; Abobo CV; Carter BL; Ball DW
    Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
    Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 9H-purin-6-amine derivatives as novel aldose reductase inhibitors for the treatment of diabetic complications.
    Zhu J; Qi G; Kuang Y; Zhao Y; Sun X; Zhu C; Hao X; Han Z
    Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200043. PubMed ID: 35466439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus.
    Patra JC; Singh O
    J Comput Chem; 2009 Nov; 30(15):2494-508. PubMed ID: 19373836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.
    Türkeş C; Arslan M; Demir Y; Çoçaj L; Nixha AR; Beydemir Ş
    J Mol Recognit; 2022 Dec; 35(12):e2991. PubMed ID: 36073557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
    Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
    J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
    Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
    Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of low micromolar dual inhibitors for aldose reductase (ALR2) and poly (ADP-ribose) polymerase (PARP-1) using structure based design approach.
    Chadha N; Silakari O
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2324-2330. PubMed ID: 28438542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications.
    Vyas B; Choudhary S; Singh PK; Singh B; Bahadur R; Malik AK; Silakari O
    Chem Biol Drug Des; 2018 Dec; 92(6):1981-1987. PubMed ID: 30030901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
    Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.
    Thiagarajan R; Varsha MKNS; Srinivasan V; Ravichandran R; Saraboji K
    Sci Rep; 2019 Oct; 9(1):14684. PubMed ID: 31604989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics.
    Kumar Pasala V; Gudipudi G; Sankeshi V; Basude M; Gundla R; Singh Jadav S; Srinivas B; Yadaiah Goud E; Nareshkumar D
    Bioorg Chem; 2021 Sep; 114():104970. PubMed ID: 34120026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
    Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and characterization of aldose reductase inhibitors from Traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking.
    Zhang H; Xu C; Tian Q; Zhang Y; Zhang G; Guan Y; Tong S; Yan J
    J Ethnopharmacol; 2021 Jan; 264():113282. PubMed ID: 32890716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
    Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
    J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs).
    Rao VR; Muthenna P; Shankaraiah G; Akileshwari C; Babu KH; Suresh G; Babu KS; Chandra Kumar RS; Prasad KR; Yadav PA; Petrash JM; Reddy GB; Rao JM
    Eur J Med Chem; 2012 Nov; 57():344-61. PubMed ID: 23124161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.